389 related articles for article (PubMed ID: 23449689)
21. Intermedin modulates hypoxic pulmonary vascular remodeling by inhibiting pulmonary artery smooth muscle cell proliferation.
Mao SZ; Fan XF; Xue F; Chen R; Chen XY; Yuan GS; Hu LG; Liu SF; Gong YS
Pulm Pharmacol Ther; 2014 Feb; 27(1):1-9. PubMed ID: 23796770
[TBL] [Abstract][Full Text] [Related]
22. Selenoprotein P Promotes the Development of Pulmonary Arterial Hypertension: Possible Novel Therapeutic Target.
Kikuchi N; Satoh K; Kurosawa R; Yaoita N; Elias-Al-Mamun M; Siddique MAH; Omura J; Satoh T; Nogi M; Sunamura S; Miyata S; Saito Y; Hoshikawa Y; Okada Y; Shimokawa H
Circulation; 2018 Aug; 138(6):600-623. PubMed ID: 29636330
[TBL] [Abstract][Full Text] [Related]
23. MicroRNA-138 and MicroRNA-25 Down-regulate Mitochondrial Calcium Uniporter, Causing the Pulmonary Arterial Hypertension Cancer Phenotype.
Hong Z; Chen KH; DasGupta A; Potus F; Dunham-Snary K; Bonnet S; Tian L; Fu J; Breuils-Bonnet S; Provencher S; Wu D; Mewburn J; Ormiston ML; Archer SL
Am J Respir Crit Care Med; 2017 Feb; 195(4):515-529. PubMed ID: 27648837
[TBL] [Abstract][Full Text] [Related]
24. Role for DNA damage signaling in pulmonary arterial hypertension.
Meloche J; Pflieger A; Vaillancourt M; Paulin R; Potus F; Zervopoulos S; Graydon C; Courboulin A; Breuils-Bonnet S; Tremblay E; Couture C; Michelakis ED; Provencher S; Bonnet S
Circulation; 2014 Feb; 129(7):786-97. PubMed ID: 24270264
[TBL] [Abstract][Full Text] [Related]
25. Let-7a-transfected mesenchymal stem cells ameliorate monocrotaline-induced pulmonary hypertension by suppressing pulmonary artery smooth muscle cell growth through STAT3-BMPR2 signaling.
Cheng G; Wang X; Li Y; He L
Stem Cell Res Ther; 2017 Feb; 8(1):34. PubMed ID: 28187784
[TBL] [Abstract][Full Text] [Related]
26. Dehydroepiandrosterone inhibits the Src/STAT3 constitutive activation in pulmonary arterial hypertension.
Paulin R; Meloche J; Jacob MH; Bisserier M; Courboulin A; Bonnet S
Am J Physiol Heart Circ Physiol; 2011 Nov; 301(5):H1798-809. PubMed ID: 21890685
[TBL] [Abstract][Full Text] [Related]
27. Oxygen sensing, mitochondrial biology and experimental therapeutics for pulmonary hypertension and cancer.
Wu D; Dasgupta A; Read AD; Bentley RET; Motamed M; Chen KH; Al-Qazazi R; Mewburn JD; Dunham-Snary KJ; Alizadeh E; Tian L; Archer SL
Free Radic Biol Med; 2021 Jul; 170():150-178. PubMed ID: 33450375
[TBL] [Abstract][Full Text] [Related]
28. Nicotinamide riboside promotes Mfn2-mediated mitochondrial fusion in diabetic hearts through the SIRT1-PGC1α-PPARα pathway.
Hu L; Guo Y; Song L; Wen H; Sun N; Wang Y; Qi B; Liang Q; Geng J; Liu X; Fu F; Li Y
Free Radic Biol Med; 2022 Apr; 183():75-88. PubMed ID: 35318101
[TBL] [Abstract][Full Text] [Related]
29. The six-transmembrane protein Stamp2 ameliorates pulmonary vascular remodeling and pulmonary hypertension in mice.
Batool M; Berghausen EM; Zierden M; Vantler M; Schermuly RT; Baldus S; Rosenkranz S; Ten Freyhaus H
Basic Res Cardiol; 2020 Nov; 115(6):68. PubMed ID: 33188479
[TBL] [Abstract][Full Text] [Related]
30. Aerobic interval training attenuates mitochondrial dysfunction in rats post-myocardial infarction: roles of mitochondrial network dynamics.
Jiang HK; Wang YH; Sun L; He X; Zhao M; Feng ZH; Yu XJ; Zang WJ
Int J Mol Sci; 2014 Mar; 15(4):5304-22. PubMed ID: 24675698
[TBL] [Abstract][Full Text] [Related]
31. Dichloroacetate prevents and reverses pulmonary hypertension by inducing pulmonary artery smooth muscle cell apoptosis.
McMurtry MS; Bonnet S; Wu X; Dyck JR; Haromy A; Hashimoto K; Michelakis ED
Circ Res; 2004 Oct; 95(8):830-40. PubMed ID: 15375007
[TBL] [Abstract][Full Text] [Related]
32. Endothelial progenitor cell-derived exosomes inhibit pulmonary artery smooth muscle cell in vitro proliferation and resistance to apoptosis by modulating the Mitofusin-2 and Ras-Raf-ERK1/2 signaling pathway.
Liu P; Gao S; Li Z; Pan S; Luo G; Ji Z
Eur J Pharmacol; 2023 Jun; 949():175725. PubMed ID: 37068578
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of mitochondrial fission prevents hypoxia-induced metabolic shift and cellular proliferation of pulmonary arterial smooth muscle cells.
Parra V; Bravo-Sagua R; Norambuena-Soto I; Hernández-Fuentes CP; Gómez-Contreras AG; Verdejo HE; Mellado R; Chiong M; Lavandero S; Castro PF
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2891-2903. PubMed ID: 28739174
[TBL] [Abstract][Full Text] [Related]
34. Enhanced Ca(2+)-sensing receptor function in idiopathic pulmonary arterial hypertension.
Yamamura A; Guo Q; Yamamura H; Zimnicka AM; Pohl NM; Smith KA; Fernandez RA; Zeifman A; Makino A; Dong H; Yuan JX
Circ Res; 2012 Aug; 111(4):469-81. PubMed ID: 22730443
[TBL] [Abstract][Full Text] [Related]
35. FOXM1 promotes pulmonary artery smooth muscle cell expansion in pulmonary arterial hypertension.
Bourgeois A; Lambert C; Habbout K; Ranchoux B; Paquet-Marceau S; Trinh I; Breuils-Bonnet S; Paradis R; Nadeau V; Paulin R; Provencher S; Bonnet S; Boucherat O
J Mol Med (Berl); 2018 Feb; 96(2):223-235. PubMed ID: 29290032
[TBL] [Abstract][Full Text] [Related]
36. HNRNPA2B1: RNA-Binding Protein That Orchestrates Smooth Muscle Cell Phenotype in Pulmonary Arterial Hypertension.
Ruffenach G; Medzikovic L; Aryan L; Li M; Eghbali M
Circulation; 2022 Oct; 146(16):1243-1258. PubMed ID: 35993245
[TBL] [Abstract][Full Text] [Related]
37. Hypoxia induces pulmonary artery smooth muscle dysfunction through mitochondrial fragmentation-mediated endoplasmic reticulum stress.
Zhuan B; Wang X; Wang MD; Li ZC; Yuan Q; Xie J; Yang Z
Aging (Albany NY); 2020 Nov; 12(23):23684-23697. PubMed ID: 33221740
[TBL] [Abstract][Full Text] [Related]
38. Effect of Mitofusin 2 on smooth muscle cells proliferation in hypoxic pulmonary hypertension.
Zhang D; Ma C; Li S; Ran Y; Chen J; Lu P; Shi S; Zhu D
Microvasc Res; 2012 Nov; 84(3):286-96. PubMed ID: 22771393
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of human bone morphogenetic protein receptor 2 does not ameliorate monocrotaline pulmonary arterial hypertension.
McMurtry MS; Moudgil R; Hashimoto K; Bonnet S; Michelakis ED; Archer SL
Am J Physiol Lung Cell Mol Physiol; 2007 Apr; 292(4):L872-8. PubMed ID: 17142350
[TBL] [Abstract][Full Text] [Related]
40. Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity.
Hernández-Alvarez MI; Thabit H; Burns N; Shah S; Brema I; Hatunic M; Finucane F; Liesa M; Chiellini C; Naon D; Zorzano A; Nolan JJ
Diabetes Care; 2010 Mar; 33(3):645-51. PubMed ID: 20032281
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
